Statins in chronic kidney disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Statins have become a mainstay therapy in cardiovascular and atherosclerotic disease. However, the use of statins in end stage kidney disease is a controversial topic. There is no evidence to support statins or other lipid lowering therapies in patients with end stage renal disease. This chapter seeks to review the epidemiology and risk factors of cardiovascular disease in the chronic kidney disease population, the literature and data regarding the beneficial and harmful effects of statins in this particular population and the international guidelines for their use. In addition, statins choices and doses in this population are reviewed.

Original languageEnglish (US)
Title of host publicationLipid Management
Subtitle of host publicationFrom Basics to Clinic
PublisherSpringer International Publishing
Pages187-199
Number of pages13
ISBN (Electronic)9783319111612
ISBN (Print)9783319111605
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Springer International Publishing Switzerland 2015.

Keywords

  • Cardiovascular disease
  • Chronic kidney disease
  • Dialysis
  • End stage renal disease
  • Glomerular filtration rate
  • Statins

Fingerprint

Dive into the research topics of 'Statins in chronic kidney disease'. Together they form a unique fingerprint.

Cite this